2006
Genetic Differentiation of Appendiceal Tumor Malignancy
Modlin IM, Kidd M, Latich I, Zikusoka MN, Eick GN, Mane SM, Camp RL. Genetic Differentiation of Appendiceal Tumor Malignancy. Annals Of Surgery 2006, 244: 52-60. PMID: 16794389, PMCID: PMC1570599, DOI: 10.1097/01.sla.0000217617.06782.d5.Peer-Reviewed Original ResearchMeSH KeywordsAdaptor Proteins, Signal TransducingAdolescentAdultAgedAged, 80 and overAntigens, NeoplasmApoptosis Regulatory ProteinsAppendiceal NeoplasmsAppendicitisBiomarkers, TumorCarcinoid TumorCell Cycle ProteinsChildChromogranin AChromograninsDiagnosis, DifferentialFemaleGene ExpressionGenetic MarkersHistone DeacetylasesHumansImmunohistochemistryMaleMiddle AgedNLR ProteinsNuclear ProteinsNucleosome Assembly Protein 1Repressor ProteinsReverse Transcriptase Polymerase Chain ReactionTrans-ActivatorsConceptsAppropriate surgical managementAppendiceal carcinoidsAppendiceal tumorsSurgical managementMAGE-D2Malignant appendiceal tumorsAppendiceal adenocarcinoidAdenocarcinoid tumorCarcinoid tumorsHistologic evidenceIncidental lesionsColorectal cancerPathologic criteriaQ-RT-PCRAppendiceal tissueGene expressionNormal mucosaTumor potentialCarcinoidsTumor behaviorAppendicitisAdenocarcinoidMorphologic assessmentTumor typesTumor malignancyUtility of molecular genetic signatures in the delineation of gastric neoplasia
Kidd M, Modlin IM, Mane SM, Camp RL, Eick GN, Latich I, Zikusoka MN. Utility of molecular genetic signatures in the delineation of gastric neoplasia. Cancer 2006, 106: 1480-1488. PMID: 16502410, DOI: 10.1002/cncr.21758.Peer-Reviewed Original ResearchMeSH KeywordsAdaptor Proteins, Signal TransducingAdenocarcinomaAdultAgedAntigens, NeoplasmCarcinoid TumorChromogranin AChromograninsDiagnosis, DifferentialFemaleGene Expression ProfilingGenetic MarkersHistone DeacetylasesHumansImmunohistochemistryMaleMiddle AgedNeoplasm InvasivenessOligonucleotide Array Sequence AnalysisPhenotypeRepressor ProteinsReverse Transcriptase Polymerase Chain ReactionStomach NeoplasmsTrans-ActivatorsConceptsType III/IVGastric carcinoidsMAGE-D2Gastric neoplasiaMolecular genetic signaturesType I/IIGenetic signaturesTumor invasionSimilar expression patternsCgA protein levelsProtein expression levelsII tumorsStromal tumorsClinical behaviorGastric adenocarcinomaGastric neoplasmsMTA1 levelsNormal mucosaImmunohistochemical analysisMolecular basisExpression patternsGene expressionTumorsGene signatureBiological rationaleQ RT-PCR Detection of Chromogranin A
Kidd M, Modlin IM, Mane SM, Camp RL, Shapiro MD. Q RT-PCR Detection of Chromogranin A. Annals Of Surgery 2006, 243: 273-280. PMID: 16432362, PMCID: PMC1448909, DOI: 10.1097/01.sla.0000197734.28551.0f.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedBiomarkers, TumorCarcinoid TumorChi-Square DistributionChildChromogranin AChromograninsFemaleHumansImmunohistochemistryMaleMiddle AgedNeuroendocrine TumorsReverse Transcriptase Polymerase Chain ReactionRNA, NeoplasmSensitivity and SpecificityConceptsGI carcinoidsGI adenocarcinomasQ-RT-PCRNormal mucosaLymph node metastasisNormal lymph nodesCgA gene expressionCgA protein levelsProtein expression levelsAppendiceal tumorsNormal LNsLiver metastasesLN metastasisLymph nodesNode metastasisAppendiceal carcinoidsNonmetastatic lesionsEpithelial tumorsCgA levelsTissue microarrayTherapeutic strategiesCarcinoidsNE cellsImmunohistochemical measurementsRT-PCR detectionThe Role of Genetic Markers— NAP1L1, MAGE-D2, and MTA1—in Defining Small-Intestinal Carcinoid Neoplasia
Kidd M, Modlin IM, Mane SM, Camp RL, Eick G, Latich I. The Role of Genetic Markers— NAP1L1, MAGE-D2, and MTA1—in Defining Small-Intestinal Carcinoid Neoplasia. Annals Of Surgical Oncology 2006, 13: 253-262. PMID: 16424981, DOI: 10.1245/aso.2006.12.011.Peer-Reviewed Original ResearchMeSH KeywordsAdaptor Proteins, Signal TransducingAdultAgedAntigens, NeoplasmBiomarkers, TumorCarcinoid TumorCell Cycle ProteinsFemaleGenetic MarkersHistone DeacetylasesHumansIntestinal NeoplasmsIntestine, SmallMaleMiddle AgedNuclear ProteinsNucleosome Assembly Protein 1Repressor ProteinsReverse Transcriptase Polymerase Chain ReactionTissue Array AnalysisTrans-ActivatorsConceptsSmall intestinal carcinoidsQuantitative reverse transcriptase-polymerase chain reactionColorectal carcinomaMAGE-D2Primary tumorLymph node metastasisImmunohistochemical expression levelsReverse transcriptase-polymerase chain reactionNonmetastatic primary tumorsTranscriptase-polymerase chain reactionHealthy tissueGastrointestinal carcinoidsLN metastasisNode metastasisIntestinal carcinoidsPrognostic utilityHealthy mucosaMalignant potentialProstate carcinomaTissue microarrayImmunohistochemical methodsCarcinomaImmunohistochemical approachMetastasisCarcinoids
2005
Microsatellite instability and gene mutations in transforming growth factor‐beta type II receptor are absent in small bowel carcinoid tumors
Kidd M, Eick G, Shapiro MD, Camp RL, Mane SM, Modlin IM. Microsatellite instability and gene mutations in transforming growth factor‐beta type II receptor are absent in small bowel carcinoid tumors. Cancer 2005, 103: 229-236. PMID: 15599934, DOI: 10.1002/cncr.20750.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedBase Pair MismatchBase SequenceCarcinoid TumorCase-Control StudiesCohort StudiesDNA Mutational AnalysisFemaleGene Expression Regulation, NeoplasticGenomic InstabilityHumansIntestinal NeoplasmsIntestine, SmallMaleMicrosatellite RepeatsMiddle AgedMolecular Sequence DataMutationProbabilityPrognosisProtein Serine-Threonine KinasesReceptor, Transforming Growth Factor-beta Type IIReceptors, Transforming Growth Factor betaReverse Transcriptase Polymerase Chain ReactionSensitivity and SpecificityConceptsSmall bowel carcinoidsSmall bowel carcinoid tumorsCarcinoid tumorsGrowth factor beta type II receptorMicrosatellite instabilityMismatch repair genesType II receptorLiver metastasesNormal mucosaII receptorsBAT-26Carcinoid tumor metastasisVariable expressionMicrosatellite stable phenotypeRepair genes
2002
RET Activation and Clinicopathologic Features in Poorly Differentiated Thyroid Tumors
Santoro M, Papotti M, Chiappetta G, Garcia-Rostan G, Volante M, Johnson C, Camp RL, Pentimalli F, Monaco C, Herrero A, Carcangiu ML, Fusco A, Tallini G. RET Activation and Clinicopathologic Features in Poorly Differentiated Thyroid Tumors. The Journal Of Clinical Endocrinology & Metabolism 2002, 87: 370-379. PMID: 11788678, DOI: 10.1210/jcem.87.1.8174.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overCarcinoma, PapillaryCell DifferentiationDrosophila ProteinsFemaleGene RearrangementHumansImmunohistochemistryLymphatic MetastasisMaleMiddle AgedOncogene Proteins, FusionPrognosisProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-retReceptor Protein-Tyrosine KinasesReverse Transcriptase Polymerase Chain ReactionSurvival AnalysisThyroid NeoplasmsConceptsRET/PTC rearrangementsRET/PTCClinicopathologic parametersRET activationInsular growth patternRelevant clinicopathologic parametersClinical characteristicsClinicopathologic featuresDistant metastasisSignificant morbidityDifferentiated tumorsHistologic evidenceMale sexAnaplastic carcinomaPatient outcomesPoor survivalEpithelial neoplasmsPapillary carcinomaLow prevalenceOncocytic featuresThyroid tumorsSurvival analysisThyroid glandMorphologic featuresSame tumor